Array Biopharma (ARRY) gains on strong earnings


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Array Biopharma Inc (NASDAQ: ARRY) shares surged 12.6% to $7.12 following a strong earnings report. Array BioPharma reported Q3 earnings of $0.37 per share on revenue of $6.6 million. Share volume was 1.1 million, compared to an all-day average of 684,000

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!